Lily Collins put a Parisian twist on naked dressing while out in London on February 9. The Emily in Paris star attended Maison Perrier's U.K. launch party in a completely sheer LBD with an unexpected ...
We sat down with Mob Entertainment's Senior Director of Creative, Film, & Games, George Krstic to talk all things Poppy ...
Nebraska became the latest state to sue Roblox on Wednesday, alleging that the popular gaming platform exploits children and misrepresents its safety practices ...
A Georgia Tech expert says debate over Roblox reflects a much bigger national reckoning over how Big Tech protects children online.
The Final Harvest announces the official 2026 release of its upcoming horror game on the Roblox platform. The project introduces players to a digital environment centered on industrial survival and ...
Eli Lilly and Co. (NYSE: LLY) on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound ...
The platform is used worldwide, and County Assistant Counsel Scott Kuhn said over half a million children in LA County are on it almost every day, and more needs to be done to protect children.
Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...
“To me it felt completely normal because I had access to it my entire childhood,” Kapri Lyons tells PEOPLE ...
A longtime member of the "Today" show family is showing support amid host Savannah Guthrie's absence from the morning talk show. Katie Couric, who co-anchored the NBC broadcast from 1991-2006, ...
Savannah Guthrie is probably never returning to the “Today” show after her mother Nancy’s heartbreaking disappearance, according to a new report. The “Today” anchor has not appeared on the NBC morning ...
The LIBRETTO-432 trial results showed that selpercatinib significantly reduced the risk of disease recurrence or death in patients with RET fusion-positive non-small cell lung cancer. This trial is ...